Literature DB >> 34758441

Neurogenic orthostatic hypotension in early stage Parkinson's disease: New insights from the first 105 patients of the BoProPark study.

Francesca Baschieri1, Luisa Sambati1, Pietro Guaraldi2, Giorgio Barletta1, Pietro Cortelli1, Giovanna Calandra-Buonaura3.   

Abstract

OBJECTIVES: The prevalence of neurogenic orthostatic hypotension (NOH, due to cardiovascular autonomic failure) at early stage of Parkinson's disease (PD) is unknown. The aims of this study are to prospectively evaluate in a cohort of PD patients recruited within 3 years from motor onset (1) cardiovascular autonomic functions by means of cardiovascular reflex tests (CRTs) and the occurrence of NOH; (2) the frequency of orthostatic symptoms with a validated questionnaire.
METHODS: We included the first 105 PD patients of the prospective "BoProPark" study. Each patient underwent CRTs (head up tilt test; Valsalva manoeuvre; deep breathing; cold face test and handgrip test) under continuous blood pressure monitoring according to standardized procedures and SCOPA-Aut questionnaire at baseline (T0) and after 16 months (T1). A group of 50 age- and sex-matched controls was used for comparison.
RESULTS: At T0 (mean age 61 ± 9 years, disease duration 19 ± 9 months) NOH was detected in 4/105 (3.8%) patients, whereas at T1 in 8/105 (7.6%). CRTs responses assessing sympathetic function were impaired at T0 in PD patients compared to controls and progressively worsened at T1. Only 1 patient at T0 and 3 at T1 with NOH reported orthostatic symptoms with low frequency, while the majority of patients reporting these symptoms did not have OH at testing.
CONCLUSIONS: Our prospective study shows that NOH is not common at early PD stage. Asymptomatic mild sympathetic impairment was observed at first evaluation and progressed with disease evolution. Secondary OH may account for the higher prevalence of OH in PD reported so far.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular autonomic failure; Cardiovascular autonomic testing; Orthostatic hypotension; Orthostatic intolerance symptoms; Parkinson's disease

Mesh:

Year:  2021        PMID: 34758441     DOI: 10.1016/j.parkreldis.2021.11.002

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  4 in total

Review 1.  Autonomic dysfunction in progressive supranuclear palsy.

Authors:  Francesca Baschieri; Maria Vitiello; Pietro Cortelli; Giovanna Calandra-Buonaura; Francesca Morgante
Journal:  J Neurol       Date:  2022-08-30       Impact factor: 6.682

2.  Sleep and Autonomic Manifestations in Parkinson's Disease Complicated With Probable Rapid Eye Movement Sleep Behavior Disorder.

Authors:  Hiroaki Fujita; Tomohiko Shiina; Hirotaka Sakuramoto; Narihiro Nozawa; Keitaro Ogaki; Keisuke Suzuki
Journal:  Front Neurosci       Date:  2022-04-08       Impact factor: 4.677

3.  Pharyngolaryngeal semiology and prognostic factors in multiple system atrophy.

Authors:  N El Fassi; Y Gallois; S Crestani; P Fichaux-Bourrin; F Ory; M Fabbri; A Pavy le Traon; V Woisard
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-05-05       Impact factor: 3.236

4.  Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson's disease phenotypes.

Authors:  Giulietta Maria Riboldi; Marco J Russo; Ling Pan; Kristen Watkins; Un Jung Kang
Journal:  NPJ Parkinsons Dis       Date:  2022-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.